2nd Clinical Trial in Batten Disease, StemCells (STEM)
October 29th, 2010
No comments
STEM initiated a 2nd clinical trial of its HuCNS-SC(R) product candidate (purified human neural stem cells) Read more…
Categories: Batten disease, NASDAQ: STEM, Phase Ib trial, Stem Cell Technology
